High prevalence of substance use disorders among adolescents who use marijuana and inhalants

2005 ◽  
Vol 78 (1) ◽  
pp. 23-32 ◽  
Author(s):  
Li-Tzy Wu ◽  
Daniel J. Pilowsky ◽  
William E. Schlenger
AIDS Care ◽  
2017 ◽  
Vol 30 (5) ◽  
pp. 604-608 ◽  
Author(s):  
Sharlene Beckford Jarrett ◽  
Winston De La Haye ◽  
Zahra Miller ◽  
J Peter Figueroa ◽  
Jacqueline Duncan ◽  
...  

2017 ◽  
Vol 41 (S1) ◽  
pp. S55-S55
Author(s):  
F. Matthys

Guideline for managing ADHD and substance use disorders (SUD)Frieda Matthys, MD, PhD.BackgroundDespite the high prevalence of ADHD in adults with SUD and the availability of an approved guideline, under diagnosis and inadequate treatment still persist. This comorbidity associates with reduced treatment effectiveness, making successful treatment in adults with ADHD and SUD a challenge.MethodsThe guideline of 2010 for recognizing and treating adult ADHD in patients with SUD is updated in 2016, in cooperation with caregivers, of the addiction centers in Belgium and based on research literature and clinical experience. The english translation is discussed by an international group of clinicians and experts to result in a consensus statement via ICASA (International Collaboration on ADHD and Substance Abuse).ResultsThis consensus presents a useful guide for the diagnosis and treatment of ADHD and SUD. Due to the lack of scientific evidence on some of the topics, the guide is a combination of evidence based and practice based recommendations.ConclusionThe management of ADHD in patients with SUD remains a challenge. Diagnosis is complicated by SUD symptoms and by the skepticism associated with the recognition of ADHD in adults. The treatment is hampered by high relapse rates and reduced effectiveness of the currently available pharmacotherapies. Combining psycho-and pharmacotherapy in an integrated treatment that covers both ADHD and SUD, may help to keep these patients in treatment.A Dutch manual for the integrated treatment of ADHD and SUD is being developed.Disclosure of interestHonorarium Lilly.Advisory board Johnson&Johnson.


2009 ◽  
Vol 34 (8) ◽  
pp. 654-661 ◽  
Author(s):  
Li-Tzy Wu ◽  
Andy C. Parrott ◽  
Christopher L. Ringwalt ◽  
Ashwin A. Patkar ◽  
Paolo Mannelli ◽  
...  

2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Daniel J. Devoe ◽  
Gina Dimitropoulos ◽  
Alida Anderson ◽  
Anees Bahji ◽  
Jordyn Flanagan ◽  
...  

Abstract Aim Individuals with anorexia nervosa (AN) often present with substance use and substance use disorders (SUDs). However, the prevalence of substance use and SUDs in AN has not been studied in-depth, especially the differences in the prevalence of SUDs between AN types [e.g., AN-R (restrictive type) and AN-BP (binge-eating/purge type]. Therefore, this systematic review and meta-analysis aimed to assess the prevalence of SUDs and substance use in AN samples. Method Systematic database searches of the peer-reviewed literature were conducted in the following online databases: MEDLINE, PsycINFO, Embase, and CINAHL from inception to January 2021. We restricted review eligibility to peer-reviewed research studies reporting the prevalence for either SUDs or substance use in individuals with AN. Random-effects meta-analyses using Freeman–Tukey double arcsine transformations were performed on eligible studies to estimate pooled proportions and 95% confidence intervals (CIs). Results Fifty-two studies met the inclusion criteria, including 14,695 individuals identified as having AN (mean age: 22.82 years). Random pooled estimates showed that substance use disorders had a 16% prevalence in those with AN (AN-BP = 18% vs. AN-R = 7%). Drug abuse/dependence disorders had a prevalence of 7% in AN (AN-BP = 9% vs. AN-R = 5%). In studies that looked at specific abuse/dependence disorders, there was a 10% prevalence of alcohol abuse/dependence in AN (AN-BP = 15% vs. AN-R = 3%) and a 6% prevalence of cannabis abuse/dependence (AN-BP = 4% vs. AN-R = 0%). In addition, in terms of substance use, there was a 37% prevalence for caffeine use, 29% prevalence for alcohol use, 25% for tobacco use, and 14% for cannabis use in individuals with AN. Conclusion This is the most comprehensive meta-analysis on the comorbid prevalence of SUDs and substance use in persons with AN, with an overall pooled prevalence of 16%. Comorbid SUDs, including drugs, alcohol, and cannabis, were all more common in AN-BP compared to AN-R throughout. Therefore, clinicians should be aware of the high prevalence of SUD comorbidity and substance use in individuals with AN. Finally, clinicians should consider screening for SUDs and integrating treatments that target SUDs in individuals with AN. Plain English Summary Individuals with anorexia nervosa (AN) may also present with substance use or have a substance use disorder (SUDs). Thus, we conducted a systematic review and meta-analysis to determine the prevalence of substance use and substance use disorders in individuals with AN. We examined published studies that reported the prevalence of either substance use or SUDs in individuals with AN. We found that substance use disorders had a 16% prevalence and that drug abuse/dependence disorders had a prevalence of 7% in those with AN. These rates were much higher in individuals with binge-eating/purging type compared to the restrictive AN. However, many specific substance use disorders and substance use types were low in individuals with AN. Nonetheless, clinicians should be aware of the high prevalence of SUD comorbidity and substance use in individuals with AN.


PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0118610 ◽  
Author(s):  
María Pedraz ◽  
Ana Isabel Martín-Velasco ◽  
Nuria García-Marchena ◽  
Pedro Araos ◽  
Antonia Serrano ◽  
...  

2020 ◽  
Vol 18 (4) ◽  
pp. 26-35 ◽  
Author(s):  
M. V. Vetrova ◽  
D. N. Kuchmenko ◽  
I. N. Genina ◽  
O. V. Goncharov ◽  
K. V. Rybakova ◽  
...  

Background. There is evidence that sleep disorders may be significantly linked to the development of the substance use disorders (SUD). However, data about the prevalence of the sleep disturbances among patients with SUD in Russia are relatively limited.Aim. To evaluate the frequency of the sleep disturbances among patients (n = 196) with alcohol (ÀD, n = 102), opioid (ÎD, n = 55) and polysubstance dependence (PD, n = 39) seeking addiction medical care.Materials and methods. We conduct a cross-sectional study of sleep disturbances among patients in St. Petersburg in 2017–2018. The modified Insomnia Severity Index (ISI) was administered to assess sleep during different periods of time: lifetime, the past 12 months, and the past 30 days.Results. All groups demonstrated relatively high presence of different sleep disorders (range: 49.0–76.5% among 196). The sleep disturbances over the past 30 days were more common in the AD group (60.8– 73.5% among 102) with the early morning awakening as the most frequent complaint. In the PD group the prevalence of lifetime sleep disturbances was high (94.9–100.0% among 39), whereas insomnia disorders were relatively rare over the past 30 days. However, it was sleep disturbances over the past 30 days that were statistically significantly more often (p < 0,05) observed in the group of patients who actively consume narcotic substances (40.2–87.2%), compared with the group of patients in remission (0–16.7%).Conclusion. The results demonstrated the high prevalence of insomnia among patients with SUD and suggested that the remission have a positive effect on the symptoms of sleep disorders. Further studies of the association between sleep disturbances and SUD progression are needed. 


2012 ◽  
Author(s):  
L. Michelle Tuten ◽  
Hendree E. Jones ◽  
Cindy M. Schaeffer ◽  
Maxine L. Stitzer

Sign in / Sign up

Export Citation Format

Share Document